Drugs with this side effect
- 5-ASA: postmarketing, 5% - 43%
- 5-azacytidine: common, 0% - 5.71%
- A77 1726: 3.35%
- Fe(III: 6%
- Forteo: 9.6%
- Gd-DTPA
- Gd-EOB-DTPA
- Glat copolymer
- Goserelin
- Humalog: 6.63% - 29.1%
- Implanon: postmarketing
- Insulin: 3% - 14.5%
- K779: 2% - 8%
- L-Dmp
- Lantus: 2.9% - 5.2%
- Leuprorelin
- Lisinopril: postmarketing, uncommon
- Lovaza
- MDV3100
- Metrodin: 0.8% - 7.23%
- Nafarelin: 5%
- NovoLog: 2% - 12%
- NuvaRing
- Octreotide
- Oestrogen: 1% - 10%
- Optison
- PGE1
- Supremon: 1.79%
- Triptorelin
- UDCA: 5.16% - 5.2%
- VACV: 1.3% - 14%
- acamprosate: frequent
- acebutolol: 1% - 4%
- acitretin: postmarketing
- aclidinium bromide: 1.57%
- alfuzosin: postmarketing, uncommon, 2.1%
- aliskiren
- allopurinol: postmarketing
- almotriptan: infrequent
- ambrisentan
- amlodipine
- amlodipine besylate
- amphotericin B: 11% - 11.1%
- anagrelide: 1-5%
- anastrozole
- anthracycline: 0% - 12%
- apraclonidine: postmarketing
- aripiprazole: 3% - 4%
- articaine
- atorvastatin
- atovaquone: 5% - 24%
- azelastine: 2.3% - 5.6%
- azithromycin
- baclofen
- balsalazide: 2% - 2.32%
- beclomethasone: 3% - 15%
- beclomethasone monopropionate: 3% - 15%
- benazepril
- bepridil
- betaxolol: postmarketing, 0% - 4%
- bexarotene: 10%
- bicalutamide
- bimatoprost: 0% - 1.9%
- bisoprolol: 2.9% - 8.3%
- boceprevir: uncommon
- brimonidine: 1.1%
- brinzolamide: 0.2% - 1%
- bromocriptine
- budesonide: 7% - 12%
- buprenorphine: 4.7% - 14.7%
- bupropion: 6.7% - 12%
- busulfan: 44%
- butorphanol
- cabergoline: 1% - 3.9%
- candesartan
- candesartan cilexetil: 1.1% - 1.3%
- capecitabine
- captopril: postmarketing
- carbamazepine
- carnitine: 6% - 11%
- carvedilol
- cefaclor
- cefditoren
- cefpodoxime
- celecoxib: 0.6% - 2.4%
- cerivastatin: 8.3%
- cetirizine
- cevimeline: 11.2%
- chlorhexidine
- ciclesonide: 0.2%
- cidofovir
- cilazapril
- cilostazol: 7% - 12%
- ciprofloxacin: rare
- citalopram: 3% - 5%
- clarithromycin: common, 2.2%
- clomipramine: 7% - 12%
- clonazepam: 2%
- clonidine
- clopidogrel
- colesevelam: 2.33% - 3.22%
- conjugated estrogens
- copolymer 1
- cyanocobalamin
- cyclophosphamide
- dalteparin
- darifenacin
- deferasirox
- delavirdine
- delta 9-THC: postmarketing
- deprenyl: 7%
- desmopressin: 1% - 12%
- diatrizoate
- diazepam
- diclofenac: 2%
- dihydroergotamine: 26%
- diltiazem: 1% - 9.57%
- dipyridamole: 0.1%
- docetaxel: 0%
- donepezil: infrequent
- doxazosin: 3%
- doxercalciferol
- doxorubicin: uncommon
- efavirenz
- eletriptan: infrequent
- emedastine
- emtricitabine: 20%
- epinastine
- eprosartan: 4%
- eribulin
- ertapenem
- esomeprazole magnesium
- estazolam: infrequent
- estradiol: 2% - 6%
- etodolac: postmarketing
- everolimus: 0% - 25%
- exemestane: 2-5%
- felbamate: 0% - 6.9%
- fenofibrate: 1.1% - 2.7%
- fenofibric acid: 2.3%
- fentanyl
- finasteride: 1% - 1.3%
- fludarabine: 3% - 11%
- flunisolide: 3.5% - 15.7%
- fluoxetine: 9% - 23%
- flurbiprofen
- fluticasone: 0.452% - 4%
- fluvastatin: 1.5% - 4.9%
- fluvoxamine: infrequent, 1.3% - 5.6%
- formoterol
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fosphenytoin: infrequent
- frovatriptan: frequent
- gabapentin: infrequent, 3.7% - 13%
- gadobenate dimeglumine
- gadodiamide
- gadolinium: postmarketing, 1.53%
- gadopentetate
- gadoteridol: 0.17%
- gadoversetamide: 0.962% - 1.53%
- galantamine: 4%
- ganciclovir
- gemcitabine
- gliclazide: 4.4% - 4.6%
- glipizide
- glutamine: 0% - 18.8%
- glycerol
- glycine
- glycopyrrolate: uncommon
- granisetron
- guanfacine
- heparin: postmarketing
- hydrochlorothiazide
- hydromorphone
- hydroxybutyrate
- ibuprofen
- imatinib
- imiquimod: uncommon, 0.1% - 3%
- indapamide: 5%
- insulin detemir: 2.2% - 6.5%
- iodixanol
- iopamidol
- iopromide
- ioxilan
- ipratropium bromide: 2% - 6%
- irbesartan: 1.6% - 2%
- irbesartan-hydrochlorothiazide: 1.6% - 2%
- irinotecan: 0% - 16%
- isomannide
- isopropyl unoprostone
- isosorbide-5-mononitrate
- itraconazole
- ivacaftor: 6%
- ketoprofen
- ketorolac: 2%
- ketorolac tromethamine
- lamivudine
- lamotrigine: 0.9% - 14%
- lanreotide
- lansoprazole: 6.4%
- lanthanum carbonate: 5% - 7%
- leflunomide: 2% - 5%
- lenalidomide: uncommon
- lercanidipine
- leuprorelin acetate
- levetiracetam: 2% - 13%
- levonorgestrel
- lidocaine
- lomefloxacin
- losartan
- loteprednol etabonate
- mannitol
- maraviroc
- meloxicam: 0.6% - 1.1%
- memantine: 2.02%
- mesna
- metformin: 4.2% - 5.6%
- methohexital
- methylphenidate
- methylprednisolone
- metipranolol
- metoprolol: very rare, rare
- metronidazole: 3.51% - 4.49%
- minocycline: 1.2% - 2.8%
- mirabegron
- mirtazapine
- mitoxantrone: 0% - 10%
- modafinil
- moexiprilat
- mometasone
- mometasone furoate
- montelukast
- morphine
- moxifloxacin
- mupirocin: 1% - 6%
- mycophenolate mofetil: 15.6% - 19%
- mycophenolic acid
- naproxen
- nedocromil sodium
- nefazodone
- nelfinavir
- niacin
- nicardipine
- nicotine
- nifedipine
- nilotinib: common
- nilutamide: 2%
- nisoldipine
- nitazoxanide
- nitroglycerin
- nizatidine: 9.8%
- ofloxacin
- olanzapine: 7% - 10%
- olmesartan: common, 0% - 3.45%
- olmesartan medoxomil
- olopatadine
- omeprazole: 2%
- oxaliplatin: common, very common, 0% - 8%
- oxcarbazepine: 2% - 10%
- oxybutynin: uncommon
- oxycodone
- paclitaxel: rare, very common
- paliperidone: 1% - 3%
- pamidronate: 0% - 6%
- pantoprazole
- paroxetine: common, frequent, 4%
- pemirolast
- pentamidine
- pentosan polysulfate: 1%
- pentostatin: 10% - 15%
- pergolide: frequent, 12.2%
- perindopril: 4.8%
- perindopril erbumine: 4.8%
- phencyclidine
- phenytoin: infrequent
- pilocarpine: 5% - 14%
- pimecrolimus: 0% - 6.7%
- posaconazole
- pramipexole: 3%
- pravastatin: 0.1% - 4%
- pregabalin: frequent
- progesterone
- propafenone
- prostacyclin
- quetiapine: frequent, 3% - 4%
- rabeprazole
- raloxifene: 10.2%
- rapamycin: 8%
- rasagiline: common, 3%
- rasburicase: 0.1%
- reboxetine
- repaglinide: 7% - 8%
- rescinnamine: 2.8%
- ribavirin: common, 5%
- rifapentine
- rifaximin
- riluzole: 6.4% - 8.9%
- rimexolone
- risedronate: 5.9%
- risperidone: 1% - 36%
- ritonavir
- rivastigmine: 4%
- rofecoxib
- roflumilast
- ropinirole: frequent, 4%
- ropivacaine: 0.9% - 1.1%
- rosuvastatin
- rufinamide
- salbutamol: postmarketing, 2.2% - 11.1%
- salmeterol: 4% - 5%
- salmon calcitonin acetate: 6.9% - 12%
- saquinavir
- sertraline: frequent
- sibutramine
- sildenafil: 2% - 4%
- sitaxsentan
- sodium ferric gluconate: 6%
- sparfloxacin
- stavudine
- tacrolimus: 2% - 6%
- tadalafil
- tamsulosin: postmarketing, uncommon, 11.6% - 17.9%
- telmisartan: common
- temsirolimus
- terazosin: 0% - 2.2%
- testosterone: postmarketing
- testosterone undecanoate
- tetrahydrozoline
- thalidomide: 0% - 11.4%
- tiagabine
- tiludronate
- tiotropium: 2% - 6%
- tizanidine: 3%
- tobramycin: 34.5%
- tolcapone: infrequent
- topiramate: 0% - 21%
- topotecan
- torasemide: 2.8%
- tramadol
- trandolapril: 0% - 1.4%
- travoprost
- treprostinil
- triamcinolone: 3.5% - 4.7%
- triamcinolone acetonide: 0% - 11.6%
- tropicamide
- trospium chloride
- trovafloxacin
- umeclidinium
- unoprostone
- v 1784: postmarketing, 0% - 5%
- valdecoxib
- valproate: 5%
- valsartan: 1.8%
- vardenafil: 9%
- venlafaxine
- verapamil: 2.7%
- voriconazole
- zidovudine: postmarketing
- zidovudine/lamivudine
- ziprasidone: uncommon, 0% - 4%
- zolmitriptan: infrequent
- zolpidem: infrequent, 1%
- zonisamide: 2%
- zopiclone
|
Drugs with this indication
|
